InsidersTradesSigma
Track the AVITA MEDICAL INC. stock price and the full management transaction log of the company, a listed equity based in Australia. Shares trade on the AU market, under the authority of ASX. Market capitalisation: €431.4m. The latest transaction was reported on 11 June 2026 (Purchase). Every trade is free.
Analysts rate AVITA MEDICAL INC. Buy (bullish), based on 4 analysts. Average price target: A$3.28.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
AVITA MEDICAL INC. is a company focused on developing tissue regeneration technologies. It is listed on the Australian Securities Exchange (ASX).